Published in Br J Cancer on March 01, 1953
Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science (2015) 21.42
The human microbiome: at the interface of health and disease. Nat Rev Genet (2012) 7.54
Cohort analysis of mortality rates as an historical or narrative technique. Br J Prev Soc Med (1956) 7.41
Some features of leukaemia mortality. Br J Prev Soc Med (1955) 4.99
Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A (2002) 3.64
Genetic progression and the waiting time to cancer. PLoS Comput Biol (2007) 3.57
Analysis of trends in cancer mortality in England and Wales during 1951-80 separating changes associated with period of birth and period of death. Br Med J (Clin Res Ed) (1982) 2.59
Age-specific incidence of cancer: Phases, transitions, and biological implications. Proc Natl Acad Sci U S A (2008) 2.32
Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer (2010) 1.92
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol (2014) 1.81
Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants. Mutat Res (2011) 1.75
How aneuploidy affects metabolic control and causes cancer. Biochem J (1999) 1.73
What does physics have to do with cancer? Nat Rev Cancer (2011) 1.59
The evolution of two mutations during clonal expansion. Genetics (2007) 1.52
Microbiome and malignancy. Cell Host Microbe (2011) 1.45
Beyond two-stage models for lung carcinogenesis in the Mayak workers: implications for plutonium risk. PLoS One (2015) 1.40
Role of genetic change in neoplasia. Br Med J (1962) 1.38
Cancer evolution: mathematical models and computational inference. Syst Biol (2014) 1.36
A new method for the analysis of cohort studies: implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. Environ Health Perspect (1983) 1.33
Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol Disord Drug Targets (2010) 1.33
Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc Natl Acad Sci U S A (2014) 1.32
Efficiency of carcinogenesis with and without a mutator mutation. Proc Natl Acad Sci U S A (2006) 1.25
Dose-response relationships for carcinogens: a review. Environ Health Perspect (1987) 1.20
The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc Natl Acad Sci U S A (2006) 1.17
Multistage models of carcinogenesis. Environ Health Perspect (1985) 1.15
Advances for studying clonal evolution in cancer. Cancer Lett (2013) 1.14
A progenitor cell origin of myeloid malignancies. Proc Natl Acad Sci U S A (2009) 1.12
A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. Radiat Environ Biophys (2009) 1.11
The influence of the thyroid in malignant disease. Br J Cancer (1954) 1.10
Stochastic modeling indicates that aging and somatic evolution in the hematopoetic system are driven by non-cell-autonomous processes. Aging (Albany NY) (2014) 1.08
Dynamics of targeted cancer therapy. Trends Mol Med (2012) 1.07
Estimating cancer risks to a population. Environ Health Perspect (1978) 1.07
Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer model. Carcinogenesis (2006) 1.06
The population genetics of multistage carcinogenesis. Proc Biol Sci (2003) 1.05
The pace of evolution across fitness valleys. J Theor Biol (2009) 1.04
The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer (2004) 1.04
A Generalized Beta model for the age distribution of cancers: application to pancreatic and kidney cancer. Cancer Inform (2009) 1.03
A new hypothesis for the cancer mechanism. Cancer Metastasis Rev (2012) 1.03
Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development. Am J Pathol (1998) 1.02
In silico models of cancer. Wiley Interdiscip Rev Syst Biol Med (2010) 1.01
Multistage carcinogenesis and the fraction at risk. J Math Biol (2004) 1.00
The mathematics of cancer: integrating quantitative models. Nat Rev Cancer (2015) 1.00
Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations. Proc Natl Acad Sci U S A (2015) 0.99
Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health (2012) 0.98
Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer (1994) 0.97
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia. Elife (2014) 0.95
Concise review: Cancer stem cells and minimal residual disease. Stem Cells (2012) 0.94
Peto's paradox and the promise of comparative oncology. Philos Trans R Soc Lond B Biol Sci (2015) 0.94
Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? Front Immunol (2014) 0.93
The real war on cancer: the evolutionary dynamics of cancer suppression. Evol Appl (2012) 0.93
Stochastic dynamics of cancer initiation. Phys Biol (2011) 0.91
Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture. BMC Med Genomics (2012) 0.91
Mutator mutations enhance tumorigenic efficiency across fitness landscapes. PLoS One (2009) 0.90
Heterogeneity in multistage carcinogenesis and mixture modeling. Theor Biol Med Model (2008) 0.90
A new view of carcinogenesis and an alternative approach to cancer therapy. Mol Med (2009) 0.90
The effect of one additional driver mutation on tumor progression. Evol Appl (2012) 0.90
Cancer models, genomic instability and somatic cellular Darwinian evolution. Biol Direct (2010) 0.90
Mouse models of sarcomas: critical tools in our understanding of the pathobiology. Clin Sarcoma Res (2012) 0.89
What can be learnt from models of incidence rates? Breast Cancer Res (2006) 0.86
Clonal evolution of glioblastoma under therapy. Nat Genet (2016) 0.85
Multistage carcinogenesis. Br J Cancer (2004) 0.84
Statistical properties of a two-stage model of carcinogenesis. Environ Health Perspect (1987) 0.84
Cohort analysis of mortality rates as an historical or narrative technique. J Epidemiol Community Health (1996) 0.84
Dynamics of growth factor production in monolayers of cancer cells and evolution of resistance to anticancer therapies. Evol Appl (2013) 0.83
MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL. Cell Cycle (2014) 0.83
A new view of radiation-induced cancer. Radiat Prot Dosimetry (2010) 0.83
Minimizing second cancer risk following radiotherapy: current perspectives. Cancer Manag Res (2014) 0.83
A new model of time scheme for progression of colorectal cancer. BMC Syst Biol (2014) 0.82
Peto's paradox and the hallmarks of cancer: constructing an evolutionary framework for understanding the incidence of cancer. Philos Trans R Soc Lond B Biol Sci (2015) 0.82
Absence of association of a single-nucleotide polymorphism in the TERT-CLPTM1L locus with age-related phenotypes in a large multicohort study: the HALCyon programme. Aging Cell (2011) 0.82
Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy. Int J Mol Sci (2016) 0.81
Auto-catalysed progression of aneuploidy explains the Hayflick limit of cultured cells, carcinogen-induced tumours in mice, and the age distribution of human cancer. Biochem J (2000) 0.81
Renal cell neoplasms contain shared tumor type-specific copy number variations. Am J Pathol (2012) 0.81
Quantitative implications of the approximate irrelevance of mammalian body size and lifespan to lifelong cancer risk. Philos Trans R Soc Lond B Biol Sci (2015) 0.81
Animal experimentation and its relevance to man. Environ Health Perspect (1979) 0.81
Patterns of proliferative activity in the colonic crypt determine crypt stability and rates of somatic evolution. PLoS Comput Biol (2013) 0.80
Statistical issues in carcinogenic risk assessment. Environ Health Perspect (1991) 0.80
Cancer stem cells: relevance to clinical transplantation. Curr Opin Oncol (2012) 0.80
Limited evidence that cancer susceptibility regions are preferential targets for somatic mutation. Genome Biol (2015) 0.79
Aging and cancer mortality: dynamics of change and sex differences. Exp Gerontol (2012) 0.79
General aspects of colorectal cancer. ISRN Oncol (2012) 0.79
It takes a (dysfunctional) village to raise a tumor. Cell (2008) 0.78
Breast cancer causes and treatment: where are we going wrong? Breast Cancer (Dove Med Press) (2013) 0.78
Histone modifications: Targeting head and neck cancer stem cells. World J Stem Cells (2014) 0.78
New stochastic carcinogenesis model with covariates: an approach involving intracellular barrier mechanisms. Math Biosci (2011) 0.78
Population dynamics of cancer cells with cell state conversions. Quant Biol (2013) 0.78
Molecular Regulation of Parturition: The Role of the Decidual Clock. Cold Spring Harb Perspect Med (2015) 0.78
Field cancerisation in colorectal cancer: a new frontier or pastures past? World J Gastroenterol (2015) 0.77
Mathematical models for translational and clinical oncology. J Clin Bioinforma (2013) 0.77
Stochastic Tunneling of Two Mutations in a Population of Cancer Cells. PLoS One (2013) 0.77
Allostatic Load and Preterm Birth. Int J Mol Sci (2015) 0.77
Tracing dynamics and clonal heterogeneity of Cbx7-induced leukemic stem cells by cellular barcoding. Stem Cell Reports (2014) 0.77
Cancer type-dependent genetic interactions between cancer driver alterations indicate plasticity of epistasis across cell types. Mol Syst Biol (2015) 0.77
Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis. Front Oncol (2013) 0.77
Parallel routes of human carcinoma development: implications of the age-specific incidence data. PLoS One (2009) 0.77
Using cell replication data in mathematical modeling in carcinogenesis. Environ Health Perspect (1993) 0.77
Modeling tumor evolutionary dynamics. Front Physiol (2013) 0.77
An argument for mechanism-based statistical inference in cancer. Hum Genet (2014) 0.77
Computational Cancer Biology: An Evolutionary Perspective. PLoS Comput Biol (2016) 0.76
The role of non-ras transforming genes in chemical carcinogenesis. Environ Health Perspect (1991) 0.75
[Theories and statistics of cancer]. Nord Med (1952) 6.34
[Theories and statistics of cancer]. Nord Med (1952) 6.34
Evidence regarding the multiple mutation theory of the cancer-inducing mechanism. Acta Genet Stat Med (1955) 0.75